These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9115929)

  • 1. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy.
    Gordon KB; Chan LS; Woodley DT
    Br J Dermatol; 1997 Mar; 136(3):415-20. PubMed ID: 9115929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging treatment for epidermolysis bullosa acquisita.
    Engineer L; Ahmed AR
    J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
    Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF
    Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial epidermolysis bullosa acquisita.
    Noe MH; Chen M; Woodley DT; Fairley JA
    Dermatol Online J; 2008 Dec; 14(12):2. PubMed ID: 19265615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy.
    Miller JL; Stricklin GP; Fine JD; King LE; Arzubiaga MC; Ellis DL
    Br J Dermatol; 1995 Sep; 133(3):467-71. PubMed ID: 8547007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.
    Vodegel RM; de Jong MC; Pas HH; Jonkman MF
    J Am Acad Dermatol; 2002 Dec; 47(6):919-25. PubMed ID: 12451379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa acquisita in childhood.
    Callot-Mellot C; Bodemer C; Caux F; Bourgault-Villada I; Fraitag S; Goudié G; Heller M; de Prost Y; Prost C
    Arch Dermatol; 1997 Sep; 133(9):1122-6. PubMed ID: 9301589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita.
    Endo Y; Tamura A; Ishikawa O; Miyachi Y; Hashimoto T
    Br J Dermatol; 1997 Nov; 137(5):783-6. PubMed ID: 9415242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory type of epidermolysis bullosa acquisita].
    Zillikens D; Erhard H; Prost C; Hashimoto T; Nishikawa T; Bröcker EB
    Hautarzt; 1994 Mar; 45(3):166-70. PubMed ID: 8175345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of epidermolysis bullosa acquisita.
    Ludwig RJ; Zillikens D
    Dermatol Clin; 2011 Jul; 29(3):493-501, xi. PubMed ID: 21605817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
    Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
    Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M; Silvente C; Lecona M; Suárez R; Lázaro P
    Clin Exp Dermatol; 2006 Jan; 31(1):71-3. PubMed ID: 16309488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and clinical features of epidermolysis bullosa acquisita.
    Caux F
    Dermatol Clin; 2011 Jul; 29(3):485-91, x. PubMed ID: 21605816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.
    Egan CA; Brown M; White JD; Yancey KB
    Clin Immunol; 2001 Nov; 101(2):146-51. PubMed ID: 11683573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).
    Niedermeier A; Eming R; Pfütze M; Neumann CR; Happel C; Reich K; Hertl M
    Arch Dermatol; 2007 Feb; 143(2):192-8. PubMed ID: 17309999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen.
    Gammon WR; Briggaman RA
    Dermatol Clin; 1993 Jul; 11(3):535-47. PubMed ID: 8365038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita.
    Liszewski W; Omland SH; Gniadecki R
    Pediatr Dermatol; 2015; 32(2):e60-1. PubMed ID: 25639865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidermolysis bullosa acquisita of childhood].
    Bordier-Lamy F; Eschard C; Coste M; Ploton D; Durlach A; Tabary T; Bernard P
    Ann Dermatol Venereol; 2009; 136(6-7):513-7. PubMed ID: 19560612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita.
    Ito Y; Kasai H; Yoshida T; Saleh MA; Amagai M; Yamagami J
    J Dermatol; 2013 Nov; 40(11):864-8. PubMed ID: 24127822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.